Vertex Pharmaceuticals (VRTX) Fails to deliver data

Key failure to deliver metrics for Vertex Pharmaceuticals:

• Last SEC data release: 2025-02-14
• Last 15 days FTD volume: S$12.73 M
• Last 3 months FTD volume: S$14.82 M
• Last year FTD volume: S$14.82 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Vertex Pharmaceuticals (VRTX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Vertex Pharmaceuticals (VRTX) - since 2013

Vertex Pharmaceuticals (VRTX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Gilead Sciences GILD	S$28.08 M	S$96.29 M	🇺🇸 USA
AbbVie ABBV	S$43.04 M	S$0.20 B	🇺🇸 USA
Merck MRK	S$80.49 M	S$0.13 B	🇺🇸 USA
Bristol-Myers Squibb BMY	S$0.16 B	S$0.47 B	🇺🇸 USA
Johnson & Johnson JNJ	S$15.09 M	S$0.22 B	🇺🇸 USA
Enanta Pharmaceuticals ENTA	S$0.15 M	S$0.98 M	🇺🇸 USA